Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: NanoFacture DNA Recovery System

Premium

NanoFacture this week commercialized the DRS (DNA Recovery System) for extracting DNA from small-volume samples of 1 to 10 μL.

The DRS integrates the company's patented electrohydrodynamic NTip technology into a compact automated device for DNA extraction from various sample types, including saliva, whole blood, and dried blood spots. The technology concentrates and purifies DNA samples onto the NTip, which is housed in a disposable cartridge using a combination of chemical affinity and capillary action. By eliminating microporous filtration and centrifugation, the DRS can be used on a full spectrum of nucleic acid targets, the company said.

The DRS instrument, which is about the size of a coffee maker and can run four samples simultaneously, is intended for rapid PCR-ready sample preparation for immediate use or long-term storage.

Greg Bruce, a researcher at the Seattle Children's Research Institute, said in a statement that the new product enables "rapid, reproducible isolation of viral DNA contained in a saliva sample. This normally requires overnight incubation followed by hours of processing, but NF DRS needed less than 10 minutes to do the same thing without the mess of phenol/chloroform. The resulting sample is compatible with PCR for a quick, reliable determination of viral load using a small volume sample."

NanoFacture said that additional protocols are in development including more biological samples (buccal swab, urine, and semen), agricultural samples, and RNAs.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.